SPG20 Back

spastic paraplegia 20 (Troyer syndrome)

External References:      Wikipedia GeneCards HUGO COSMIC Google Scholar

NCBI Description of SPG20
This gene encodes a protein containing a MIT (Microtubule Interacting and Trafficking molecule) domain, and is implicated in regulating endosomal trafficking and mitochondria function. The protein localizes to mitochondria and partially co-localizes with microtubules. Stimulation with epidermal growth factor (EGF) results in protein translocation to the plasma membrane, and the protein functions in the degradation and intracellular trafficking of EGF receptor. Multiple alternatively spliced variants, encoding the same protein, have been identified. Mutations associated with this gene cause autosomal recessive spastic paraplegia 20 (Troyer syndrome).

Community Annotation of SPG20 Add / Edit SPG20: Annotations

No community annotations yet for SPG20.
Sort mutations by: Tumor type  Mutation type  Position  
Straightedge cursor Expand

Figure notes


• "Mouse over" a mutation to see details.
• Missense green saturation indicates evolutionary conservation of the mutated positions.
• Red hashes in protein strip are splice sites.
• Blue-white-red bars are log2 copy ratio distributions (–1 to +1) from Zack et al. (2013).


Legend

SPG20 is highly significantly mutated in
(none)
SPG20 is significantly mutated in
(none)
SPG20 is near significance in
(none)

Click on a tumor type to see its full list of significant genes.

Data details


• Mutation list for SPG20